³»Á¤º¸

ÁÖ¹®Á¶È¸.°ü¸®

Ä¿¹Â´ÏƼ

¼Ö·ç¼Ç °ü·Ã °Ô½ÃÆÇ
 


 

Å׸¶Çü ÀÚÀ¯°Ô½ÃÆÇ

 

¤ýÀÛ¼ºÀÚ biolove
¤ýÀÛ¼ºÀÏ 2011/11/25 12:28
¤ýȨÆäÀÌÁö http://www.allfor.kr
¤ýºÐ ·ù °Ç°­.´ÙÀ̾îÆ®
¤ýÃßõ: 0  ¤ýÁ¶È¸: 1090      
¤ýIP: 115.xxx.217
ÇØ¿­ÁøÅëÁ¦ ¼Ò·®¸¸ »ó½À°ú¿ëÇصµ Ä¡¸íÀû!
http://www.koreaherald.com/national/Detail.jsp?newsMLId=20111124000530   Staggered acetaminophen overdose and delayed presentation after overdose are associated with adverse outcomes, according to a study.

The research by Darren G.N. Craig, from the Royal Infirmary of Edinburgh in the United Kingdom, and colleagues was published in the British Journal of Clinical Pharmacology.


(MCT)


They examined the clinical impact of staggered acetaminophen overdoses and delayed presentation after an overdose.

A total of 663 patients were admitted with acetaminophen-induced severe liver injury between 1992 and 2008, of whom 161 patients had taken a staggered overdose.

"Both delayed presentation and staggered overdose pattern are associated with adverse outcomes following (acetaminophen) overdose. These patients are at increased risk of developing multiorgan failure," the authors wrote in

The investigators found that, compared with single time-point overdose patients, staggered overdose patients were significantly older and had a greater likelihood of alcohol abuse.

They were also more likely to be encephalopathic on admission and to need mechanical ventilation or renal replacement therapy. Staggered overdose patients had significantly higher mortality rates (37.3 versus 27.8 percent), despite lower total ingested acetaminophen doses and lower admission serum alanine aminotransferase levels.

However, staggered overdose was not an independent predictor of death. The most frequent reason for repeated supratherapeutic ingestion was relief of pain (58.2 percent).
<Çѱ۱â»ç>

"ÇØ¿­ÁøÅëÁ¦ `¼Ò·® »ó½À °ú¿ë' Ä¡¸íÀû"

ÇØ¿­ÁøÅëÁ¦·Î ³Î¸® »ç¿ëµÇ´Â ÆĶó¼¼Å¸¸ô(¾Æ¼¼ Æ®¾Æ¹Ì³ëÆæ)À» ÀûÀº ¾çÀÌ¶óµµ °ú¿ëÀ» Áö¼ÓÇϸé Ä¡¸íÀûÀÏ ¼ö ÀÖ´Ù´Â ÁöÀûÀÌ ³ª¿Ô´Ù.

½ºÄÚƲ·£µå ¿¡µç¹ö·¯´ëÇÐÀÇ ¿¬±¸ÆÀÀº ºÎ¼³ ´ëÇÐ º´¿ø¿¡¼­ Áö³­ 16³â°£ ÆĶó¼¼Å¸ ¸ô·Î ÀÎÇÑ °£ ¼Õ»ó ¼Ò°ßÀ» º¸ÀΠȯÀÚ 663¸íÀÇ ÀÇ·á ±â·ÏÀ» Á¶»çÇØ 23ÀÏ ¿µ±¹ ÀÓ»ó¾à ÇÐÀú³Î¿¡ ¹ßÇ¥Çß´Ù.

ÀÌ °¡¿îµ¥ 161°ÇÀÌ `²ÙÁØÇÑ °ú¿ë'À¸·Î ÀÎÇØ °£À̳ª ³ú ¼Õ»ó, ½ÅÀåÅõ¼® µîÀÇ Ä¡¸íÀûÀÎ °á°ú·Î À̾îÁø °ÍÀ¸·Î º¸°íµÆ´Ù.

¿¬±¸ÆÀÀº À§ÇèÇÑ ¿ë·®¿¡ ´ëÇØ ¸î ÀÏ ¶Ç´Â ¸î ÁÖ, ¸î ´Þ¿¡ °ÉÃÄ ±ÔÄ¢ÀûÀ¸·Î Á¶±Ý¾¿ ´õ º¹¿ëÇÒ °æ¿ì¶ó°í ¼³¸íÇß´Ù.

ÀÌ´Â °íÁúÀûÀÎ ÅëÁõÀ» °®°í Àִ ȯÀÚµéÀÌ ÁøÅëÀ» À§ÇØ ½À°üÀûÀ¸·Î º¹¿ëÇÏ´Â °Í µµ Ä¡¸íÀûÀÏ ¼ö ÀÖÀ½À» ÀǹÌÇÏ´Â °ÍÀÌ´Ù.

ƯÈ÷ ÇѲ¨¹ø¿¡ ¸¹Àº ¾çÀ» º¹¿ëÇÏ´Â °Í º¸´Ù ¿ÀÈ÷·Á ¿À·£ ±â°£¿¡ °ÉÃÄ Áö¼ÓÀûÀ¸·Î Á¶±Ý¾¿ °ú¿ëÇÏ´Â °ÍÀÌ ´õ ÁÁÁö ¾Ê´Ù°í ¿¬±¸ÆÀÀº °á·ÐÁö¾ú´Ù.

¿¬±¸ÆÀÀº "ÅëÁõÀ» ¿ÏÈ­Çϱâ À§ÇØ ¾àÀ» º¹¿ëÇÑ »ç¶÷µéÀº ÀڽŵéÀÌ °ú¿ëÇÏ°í ÀÖ´Ù ´Â »ç½ÇÀ» ¾ËÁö ¸øÇÏ°í ÀÖ°í °ú¿ë¿¡ µû¸¥ Áõ»óÀ̳ª °£ ¼Õ»ó µîµµ ÀνÄÇÏÁö ¸øÇÏ°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù"°í ½É°¢¼ºÀ» ÁöÀûÇß´Ù.

¿¬±¸ÆÀÀº ÀÌ´Â »ý¸íÀ» À§ÇùÇÏ´Â °ÍÀÌÁö¸¸ ÀÇ»ç¿Í ȯÀÚµéÀÌ ¸ðµÎ ³Ê¹«µµ °£°úÇÏ´Â ºÎºÐÀ̶ó°í °­Á¶Çß´Ù.

Ç÷¾× °Ë»ç¸¦ ÇÏ´õ¶óµµ ÇØ¿­ÁøÅëÁ¦¸¦ ÇѲ¨¹ø¿¡ ¸¹ÀÌ º¹¿ëÇÒ ¶§¿Í °°Àº Áõ»óÀÌ ÃÊ ±â¿¡´Â ³ªÅ¸³ªÁö ¾Ê±â ¶§¹®¿¡ ÀÇ»çµéÀÌ °£°úÇϱ⠽±´Ù´Â °ÍÀÌ´Ù.

Äɳ׽º ½É½¼ ¹Ú»ç´Â BBC¿ÍÀÇ ÀÎÅͺ信¼­ "ÀÚ»ìÀ» ½ÃµµÇÏ´Â °æ¿ìó·³ Çѹø¿¡ ¸¹ Àº ¾çÀ» º¹¿ëÇÏÁöµµ ¾Ê´õ¶óµµ ²ÙÁØÈ÷ °ú¿ëÇÏ¸é ¼Õ»óÀÌ ´©ÀûµÅ Ä¡¸íÀûÀÏ ¼ö ÀÖ´Ù"°í °æ°íÇß´Ù. (¿¬ÇÕ´º½º)
   
   
¹øÈ£     ±Û Á¦ ¸ñ  ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
74 ¾ß䡤°èÀý°úÀÏ ÀÍÇô¼­ °¥¾Æ ¸¶½Ã´Ï Çص¶µÇ³×/ °£ ±â´É °³¼±, ÇǷΠȸº¹ 2014/04/08 (È­) 1297
73 µå¶ó¼¼³ª ¸¶Áö³ªÅ¸ (Dracaena marginnata) 2013/05/26 (ÀÏ) 1284
72 "ÇѹÌFTA Âù¼ºÀÇ¿ø, ÃѼ±¼­ ¹Ýµå½Ã ¶³¾î¶ß¸°´Ù" [1] 2011/11/23 (¼ö) 1283
71 QRÄÚµå¿Í À½¸ð·Ð [31] 2011/11/23 (¼ö) 1261
70 [°Ç°­]¼ú ¾È ¸¶½Ã´Ï ±¦Âú´Ù?¡¦°£ÀÌ ºÎÀº ´ç½Å [3] ±è¿µ±æ 2011/10/28 (±Ý) 1242
69 ÇÏ·ç Å°À§ 3°³¾¿ ¸ÔÀ¸¸é Ç÷¾Ð ³·¾ÆÁø´Ù ¿ÃÆ÷¼ÒÇÁÆ® 2011/11/19 (Åä) 1239
68 ÇÑ´«¿¡ º¸´Â 3´ë Æ÷ÅÐ 2014³â ½ÇÀû (´ÙÀ½. ³×À̹ö. ³×ÀÌÆ®) 2014/08/02 (Åä) 1233
67 ±Ç·Â°ú ±â¾÷ ½Î¿ò¿¡ Åýó뵿ÀÚ¸¸ Á×À» ¸À 2013/02/21 (¸ñ) 1226
66 ÁÖ¿ä °ø°ø±â°ü ¿µ¹® À¥, ÇØ¿Ü °Ë»ö¿£Áø¿¡ ¾È °É¸°´Ù 2013/12/06 (±Ý) 1203
65 "¹æÇÑ ñé°ü±¤°´ ¿À·¡ ¸Ó¹°°í ¾¸¾¸ÀÌ Å©´Ù" [20] 2013/12/06 (±Ý) 1200
64 ÇѾàÀç·áÀÎ ¸ñ´ÜÇÇ¿¡¼­ Ç׾Ϲ°Áú ¹ß°ß 2011/09/01 (¸ñ) 1176
63 ÆùÀ̾ß, Æеå¾ß? »ï¼º '°¶·°½Ã³ëÆ®' Á÷Á¢ ½áº¸´Ï... 2011/12/01 (¸ñ) 1174
62 ÀüÀÚÃ¥ DRM ȣȯ ¿Ö ¾î·Æ³ª¡¦¡¯¿µ¾÷ºñ¹Ð¡¯ ¶§¹® 2011/11/15 (È­) 1144
61 »ï¼ºÀüÀÚ, ¡®°¶·°½Ã ³ëÆ®¡¯ Ưȭ ¾ÖÇø®ÄÉÀÌ¼Ç ´ë°Å Ãâ½Ã [3] 2011/12/19 (¿ù) 1132
60 ¡®¿ÏÀü½ÄÇ°¡¯ °è¶õÀÌ ÁÁÀº ´Ù¼¸ °¡Áö [25] 2012/01/01 (ÀÏ) 1128
59 ¼¼Á¾ÀÇ ÇÑ±Û ¹ÝÆ÷, ½ÇÁ¦´Â µå¶ó¸¶¿Í ´Þ¶ú´Ù [2] 2011/12/01 (¸ñ) 1105
58 °¨±â¿Í µ¶°¨ °íÄ¡´Â ÀÚ¿¬ Ä¡·áÁ¦´Â? 2012/01/01 (ÀÏ) 1104
57 ±¹³» ¿¬±¸Áø, Áٱ⼼Æ÷ ÀÌ¿ë ÅðÇ༺°üÀý¿° Ä¡·á¹ý °³¹ß ¿ÃÆ÷¼ÒÇÁÆ® 2011/11/26 (Åä) 1104
56 ´Þ°¿, Ç÷¾Ð°­ÇÏ ¿ªÇÒ¡¦¸¾²¯ ¸Ô¾îµµ µÈ´Ù 2012/01/01 (ÀÏ) 1099
55 ¡°Ã¤¼Ò¡¤°úÀÏ ¸¹ÀÌ ¸ÔÀ¸¶ó´Âµ¥¡¦¡± ¾î¶»°Ô? [1] 2012/01/01 (ÀÏ) 1098
54 ±èÁ¤ÀÏ °æÈ£¿ø Ȥµ¶ ÈÆ·Ã ¿µ»ó¿¡ °æ¾Ç [2] 2011/12/24 (Åä) 1097
53 ÇØ¿­ÁøÅëÁ¦ ¼Ò·®¸¸ »ó½À°ú¿ëÇصµ Ä¡¸íÀû! biolove 2011/11/25 (±Ý) 1090
52 ¾Ï, ºÒÄ¡º´ ¾Æ´Ï´Ù¡¥10³â »ýÁ¸À² 51% ±è¿µ±æ 2011/10/28 (±Ý) 1087
51 ¿ÀÈÄ 3½Ã¿¡ Á¹¸°´Ù¸é? ´Þ°¿À» ¸Ô¾î¶ó 2012/01/01 (ÀÏ) 1085
50 Áß¼º¹ÌÀÚ°¡ ºûº¸´Ù ºü¸£´Ù°í? ³ëº§»ó ±³¼ö ¡°NO¡± ±è¿µ±æ 2011/10/28 (±Ý) 1076
49 ¿ì¸® ¸öÀÇ Áö¹æÀ» Å¿ì´Â À½½Ä 2012/01/01 (ÀÏ) 1073
48 Åë¹Ð - Çö¹Ì ½Ä»ç, ½ÉÀ庴 À§Çè È® ³·Ãá´Ù 2012/01/01 (ÀÏ) 1072
47 ä¼Ò¸¦ ¸¹ÀÌ ¸ÔÀ» ¼ö ÀÖ´Â ¿ä·É 7°¡Áö 2012/01/01 (ÀÏ) 1068
46 ¡®½º¸¶Æ®Æù+ÅÂºí¸´¡¯ °¶·°½Ã³ëÆ® ù ¼± ±è¿µ±æ 2011/10/28 (±Ý) 1063
45 °¡Ä¡ÅõÀÚ¿¡ ´ëÇؼ­ À߸ø ¾Ë·ÁÁø »ý°¢µé ¿ÃÆ÷¼ÒÇÁÆ® 2011/11/26 (Åä) 1057
1234567

 

 

 

Àå¹Ù±¸´Ï 0
»óÇ°º¸°üÇÔ 0
¿À´Ãº»¸ñ·Ï 2
°è»ê±â
Æ÷Åа˻ö
ȸ»ç¼Ò°³ £ü  ±¤°í¹®ÀÇ £ü  Á¦ÈÞ¹®ÀÇ £ü  ÀÌ¿ë¾à°ü £ü  û¼Ò³â º¸È£Á¤Ã¥ £ü  °³ÀÎÁ¤º¸ Ãë±Þ¹æħ £ü  °í°´¼¾ÅÍ £ü  »çÀÌÆ®¸Ê
ÁÖ¼Ò : ¼­¿ïƯº°½Ã ¼ºµ¿±¸ ¿ë´ä25±æ 15-1(¿ë´äµ¿) | »óÈ£ : ¿ÃÆ÷¼ÒÇÁÆ®(allfor.kr) | ´ëÇ¥ÀÚ:±è¿µ±æ | ¾÷Å : ¼­ºñ½º.¼Ò¸Å | Á¾¸ñ : ȨÆäÀÌÁöÁ¦ÀÛ. ¼Ö·ç¼Ç°³¹ß. Åë½ÅÆǸŠE-MAIL : admin@allfor.kr | ¢Ï : 070-8116-9964 | 010-5711-7987 | »ç¾÷ÀÚµî·Ï¹øÈ£ : 263-46-00104 | °³ÀÎÁ¤º¸°ü¸® Ã¥ÀÓÀÚ : ±è¿µ±æ